FTDZX Mutual Fund (Franklin Biotechnology Discovery Fund Advisor Class) is managed by Franklin Templeton Investments (US) with $154.0M in net assets. FTDZX expense ratio is 0.77%, holding 94 positions across sectors including Health Care, Unknown, Financials. Inception date: 2009-09-01.

FTDZX performance shows a YTD return of 4.11%. The 1-year return is 55.65% and the 5-year return is 7.61%. FTDZX dividend yield stands at 2.10%, paid annually.

FTDZX top holdings include Gilead Sciences Inc (5.6%), Nvaesrtex Pharmaceuticals Inc (4.6%), Amgen Inc. (4.5%), Argenx Se Spon Adr Each Rep 1 Ord Shs (4.1%), Regeneron Pharmaceuticals, Inc. (4.1%). View all FTDZX holdings, sector breakdown, or dividend history.

FTDZX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FTDZX alternatives are available via the screener, along with tax-loss harvesting opportunities.